Fluoropyrimidine modulation of the anti-tumor immune response―prospects for improved colorectal cancer treatment

WH Gmeiner - Cancers, 2020 - mdpi.com
Chemotherapy modulates the anti-tumor immune response and outcomes depend on the
balance of favorable and unfavorable effects of drugs on anti-tumor immunity. 5-Florouracil …

Dihydropyrimidine dehydrogenase-mediated resistance to 5-fluorouracil: Mechanistic investigation and solution

H Verma, G Narendra, B Raju, PK Singh… - ACS Pharmacology & …, 2022 - ACS Publications
5-Fluorouracil (5-FU) is one of the most widely used chemotherapeutics for the treatment of
cancers associated with the aerodigestive tract, breast, and colorectal system. The efficacy …

A rodent model of human-dose-equivalent 5-fluorouracil: toxicity in the liver, kidneys, and lungs

MC da Silva, LC Fabiano, KC da Costa Salomão… - Antioxidants, 2023 - mdpi.com
5-Fluorouracil (5-FU) is a chemotherapy drug widely used to treat a range of cancer types,
despite the recurrence of adverse reactions. Therefore, information on its side effects when …

[HTML][HTML] KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer

C Porta, A Bamias, FR Danesh, A Dębska-Ślizień… - Kidney international, 2020 - Elsevier
The association between kidney disease and cancer is multifaceted and complex. Persons
with chronic kidney disease (CKD) have an increased incidence of cancer, and both cancer …

A framework for the analysis of polar anticancer drugs in wastewater: On-line extraction coupled to HILIC or reverse phase LC-MS/MS

MA Vaudreuil, SV Duy, G Munoz, A Furtos, S Sauvé - Talanta, 2020 - Elsevier
With the consumption of chemotherapy agents, residues of anticancer drugs may be
increasingly found in hospital and municipal wastewaters. Quantification of these highly …

Chapter 2: indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney …

H Nishiyama, T Inoue, Y Koizumi, Y Kobayashi… - International Journal of …, 2023 - Springer
This comprehensive review discusses the dosing strategies of cancer treatment drugs for
patients with impaired kidney function, specifically those with chronic kidney disease (CKD) …

Why and when to measure ammonemia in cirrhosis?

M Mallet, N Weiss, D Thabut, M Rudler - Clinics and research in hepatology …, 2018 - Elsevier
Hyperammonemia plays a key role in the pathophysiology of hepatic encephalopathy (HE)
and most HE treatments are ammonia-lowering drugs. However, the usefulness of …

Fluoropyrimidine usage in cases with hyperammonemia: real-world data study using the Japanese Adverse Drug Event Report (JADER) database

M Oura, F Oguro, N Agatsuma, H Imamaki… - Cancer Chemotherapy …, 2023 - Springer
Purpose Fluoropyrimidines are anticancer drugs and can cause hyperammonemia both
intravenously and orally. Renal dysfunction may interact with fluoropyrimidine to cause …

Hyperammonemia and lactic acidosis in adults: Differential diagnoses with a focus on inborn errors of metabolism

M Tchan - Reviews in Endocrine and Metabolic Disorders, 2018 - Springer
The adult endocrinologist may be asked to consult on a patient for unexplained biochemical
disturbances that could be caused by an underlying inborn error of metabolism. A genetic …

Removal rate of 5-fluorouracil and its metabolites in patients on hemodialysis: a report of two cases of colorectal cancer patients with end-stage renal failure

H Imamaki, M Oura, F Oguro, Y Nishikawa… - Cancer Chemotherapy …, 2024 - Springer
Purpose Hyperammonemia is a serious adverse effect of 5-fluorouracil (5FU) administration.
Hemodialysis can be used for its management, but detailed data on the concentrations and …